Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

Low-abundance regulatory peptides, including metabolically important gut hormones, have shown promising therapeutic potential. Here, we present a streamlined mass spectrometry-based platform for identifying and characterizing low-abundance regulatory peptides in humans. We demonstrate the clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wewer Albrechtsen, Nicolai J., Hornburg, Daniel, Albrechtsen, Reidar, Svendsen, Berit, Toräng, Signe, Jepsen, Sara L., Kuhre, Rune E., Hansen, Marie, Janus, Charlotte, Floyd, Andrea, Lund, Asger, Vilsbøll, Tina, Knop, Filip K., Vestergaard, Henrik, Deacon, Carolyn F., Meissner, Felix, Mann, Matthias, Holst, Jens J., Hartmann, Bolette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909640/
https://www.ncbi.nlm.nih.gov/pubmed/27322465
http://dx.doi.org/10.1016/j.ebiom.2016.03.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909640/
https://www.ncbi.nlm.nih.gov/pubmed/27322465
http://dx.doi.org/10.1016/j.ebiom.2016.03.034

Ejemplares similares